Pacira BioSciences Earnings
NASDAQ: PCRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$0.47
Pacira BioSciences earnings summary
Pacira BioSciences is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $0.47. In its most recent report on Aug 4, 2026 (Q2 2026), PCRX posted EPS of $0.12. Revenue for the quarter was $192.4 million.
Across the last 16 reports, PCRX shares moved an average of 7.3% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
PCRX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $0.12 | — | -8.1% |
| Apr 30, 2026 | — | $0.07 | — | -5.3% |
| Feb 26, 2026 | — | $0.05 | — | +0.4% |
| Nov 6, 2025 | — | $0.12 | — | +7.8% |
| Aug 5, 2025 | — | $-0.11 | — | -1.6% |
| May 8, 2025 | — | $0.10 | — | +2.9% |
| Feb 27, 2025 | — | $0.38 | — | -2.8% |
| Nov 6, 2024 | — | $-3.11 | — | -3.7% |
| Jul 30, 2024 | — | $0.39 | — | -45.0% |
| May 7, 2024 | — | $0.19 | — | +4.8% |
| Feb 29, 2024 | — | $0.58 | — | +8.8% |
| Nov 2, 2023 | — | $0.23 | — | -8.2% |
| Aug 2, 2023 | — | $0.51 | — | -4.8% |
| May 3, 2023 | — | $-0.43 | — | -2.3% |
| Feb 28, 2023 | — | $-0.19 | — | -4.8% |
| Nov 3, 2022 | — | $-0.02 | — | +6.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.